河南省中医局印发《"十三五"中医药发展规划》:2020年中医药强省建设初见成效

2017-10-27 赵 丹 中国中医

日前,河南省中医管理局印发《“十三五”中医药发展规划》,提出到2020年,中医药强省建设初见成效,中医药服务体系进一步完善,实现人人享有基本中医药服务的目标,中药产业不断壮大,中医药发展部分指标居全国前列。

日前,河南省中医管理局印发《“十三五”中医药发展规划》,提出到2020年,中医药强省建设初见成效,中医药服务体系进一步完善,实现人人享有基本中医药服务的目标,中药产业不断壮大,中医药发展部分指标居全国前列。

《规划》从中医药服务能力、养生保健服务、中医药传承创新、中医药人才队伍建设、中医药文化发展和中医药信息化建设等6个方面明确了“十三五”期间该省中医药发展的重点工作。

《规划》指出不断完善中医药服务体系,建立健全以公立中医医疗机构为主体,非公立中医医疗机构共同发展的中医药服务体系;实施中医临床优势培育工程,加快各级中医专科建设;促进中西医结合,围绕重点病种,在儿科、老年肺病、脑病等重大疑难疾病和急危重症方面,开展中西医临床协作,促进中西医临床协作机制建设和服务模式创新。

实施中医治未病健康工程,支持社会力量举办中医养生保健机构并鼓励中医医院以品牌、技术、人才等优势资源与社会资本开展合作;探索设立中医特色医养结合机构,规划建设一批以保健养生、医疗康复为主的养老产业园区,打造具有河南特色的中医药健康旅游品牌。

编纂出版《河南省名中医学术经验荟萃》系列丛书,开展民间中医特色疗法和中药验方收集、整理、研究评价及推广;建立中医药研发重大专项,建立健全中医药协同创新体制机制;加强对医疗机构使用中药饮片和配制中药制剂的管理;开展中成药和中药饮片临床综合评价试点。

深入实施省中医临床学科领军人才和重点学科(专科)学术带头人培养计划,推进中医住院医师规范化培训,建立健全基层中医药人才培养培训制度;探索并强化中医药院校教育和中医师承教育模式;探索建立中医药人才评价评选体系,建立名老中医药专家学术传承保障机制。

《规划》提出,深入开展覆盖省市县乡村的中医药文化科普活动,建设一支中医药文化专业队伍;谋划编纂《河南中医志》和地方中医志,出版河南中医药文化研究丛书;筹备拍摄河南中医药形象宣传片;在中医医疗、教育、科研、制药、服务业发展等方面发挥省内资源优势,加强国内外深度合作与交流。

建设河南省中医药数据中心,搭建中医药信息平台,建设中医药业务信息系统并建立中医药综合统计网络直报体系;完善以医院管理和中医电子病历为重点的中医医院信息系统建设,实施基层医疗卫生机构中医诊疗区(中医馆)健康信息平台建设项目;鼓励探索“互联网+”中医医疗服务创新。

《规划》明确,各地要把中医药优先发展列入卫生计生发展重大战略,纳入经济社会发展总体规划,加大财政投入力度,鼓励基层医疗卫生机构提供中医药适宜技术和服务;切实加强中医药管理机构和队伍建设,积极在中医药发展综合改革试验区开展政策试点,为新形势下中医药发展提供实践经验。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1672488, encodeId=eb0c16e2488b6, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Apr 12 16:41:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907312, encodeId=10fc190e312c4, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Dec 09 16:41:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993392, encodeId=2e40199339246, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Tue Dec 26 20:41:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900059, encodeId=e36a190005919, content=<a href='/topic/show?id=cd7e6451889' target=_blank style='color:#2F92EE;'>#河南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64518, encryptionId=cd7e6451889, topicName=河南省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Apr 05 12:41:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409137, encodeId=de0d140913ec0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Oct 28 23:41:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
    2018-04-12 respect
  2. [GetPortalCommentsPageByObjectIdResponse(id=1672488, encodeId=eb0c16e2488b6, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Apr 12 16:41:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907312, encodeId=10fc190e312c4, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Dec 09 16:41:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993392, encodeId=2e40199339246, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Tue Dec 26 20:41:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900059, encodeId=e36a190005919, content=<a href='/topic/show?id=cd7e6451889' target=_blank style='color:#2F92EE;'>#河南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64518, encryptionId=cd7e6451889, topicName=河南省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Apr 05 12:41:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409137, encodeId=de0d140913ec0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Oct 28 23:41:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1672488, encodeId=eb0c16e2488b6, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Apr 12 16:41:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907312, encodeId=10fc190e312c4, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Dec 09 16:41:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993392, encodeId=2e40199339246, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Tue Dec 26 20:41:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900059, encodeId=e36a190005919, content=<a href='/topic/show?id=cd7e6451889' target=_blank style='color:#2F92EE;'>#河南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64518, encryptionId=cd7e6451889, topicName=河南省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Apr 05 12:41:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409137, encodeId=de0d140913ec0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Oct 28 23:41:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1672488, encodeId=eb0c16e2488b6, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Apr 12 16:41:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907312, encodeId=10fc190e312c4, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Dec 09 16:41:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993392, encodeId=2e40199339246, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Tue Dec 26 20:41:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900059, encodeId=e36a190005919, content=<a href='/topic/show?id=cd7e6451889' target=_blank style='color:#2F92EE;'>#河南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64518, encryptionId=cd7e6451889, topicName=河南省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Apr 05 12:41:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409137, encodeId=de0d140913ec0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Oct 28 23:41:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
    2018-04-05 lxg951
  5. [GetPortalCommentsPageByObjectIdResponse(id=1672488, encodeId=eb0c16e2488b6, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Apr 12 16:41:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907312, encodeId=10fc190e312c4, content=<a href='/topic/show?id=85fe35655ea' target=_blank style='color:#2F92EE;'>#十三五#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35655, encryptionId=85fe35655ea, topicName=十三五)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Dec 09 16:41:00 CST 2017, time=2017-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993392, encodeId=2e40199339246, content=<a href='/topic/show?id=be0921510a0' target=_blank style='color:#2F92EE;'>#中医药发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21510, encryptionId=be0921510a0, topicName=中医药发展)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Tue Dec 26 20:41:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900059, encodeId=e36a190005919, content=<a href='/topic/show?id=cd7e6451889' target=_blank style='color:#2F92EE;'>#河南省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64518, encryptionId=cd7e6451889, topicName=河南省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Apr 05 12:41:00 CST 2018, time=2018-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409137, encodeId=de0d140913ec0, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Oct 28 23:41:00 CST 2017, time=2017-10-28, status=1, ipAttribution=)]
    2017-10-28 cathymary